Andres Maldonado
Stock Analyst at HC Wainwright & Co.
(2.01)
# 2,904
Out of 4,873 analysts
96
Total ratings
31.58%
Success rate
-3.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IBRX ImmunityBio | Reiterates: Buy | $8 | $2.76 | +189.86% | 4 | Jun 4, 2025 | |
| AURA Aura Biosciences | Assumes: Buy | $22 | $6.15 | +258.01% | 1 | May 28, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Reiterates: Buy | $10 | $1.30 | +672.20% | 1 | May 15, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Maintains: Buy | $50 → $40 | $7.89 | +406.97% | 2 | May 7, 2025 | |
| TCRX TScan Therapeutics | Maintains: Buy | $15 → $10 | $1.45 | +589.66% | 1 | May 7, 2025 | |
| ERAS Erasca | Reiterates: Buy | $6 | $1.39 | +331.65% | 10 | Apr 30, 2025 | |
| FHTX Foghorn Therapeutics | Reiterates: Buy | $13 | $4.90 | +165.31% | 1 | Apr 30, 2025 | |
| STRO Sutro Biopharma | Reiterates: Neutral | $2 | $0.80 | +150.38% | 1 | Apr 29, 2025 | |
| TARA Protara Therapeutics | Reiterates: Buy | $23 | $2.88 | +698.61% | 1 | Apr 28, 2025 | |
| CGON CG Oncology | Reiterates: Buy | $75 | $25.66 | +192.28% | 13 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $6.48 | +455.56% | 14 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $6 | $2.50 | +140.00% | 5 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.25 | +1,100.00% | 16 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $3.02 | +727.81% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $50 | $33.28 | +50.24% | 13 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.34 | +198.51% | 11 | Nov 11, 2024 |
ImmunityBio
Jun 4, 2025
Reiterates: Buy
Price Target: $8
Current: $2.76
Upside: +189.86%
Aura Biosciences
May 28, 2025
Assumes: Buy
Price Target: $22
Current: $6.15
Upside: +258.01%
Zentalis Pharmaceuticals
May 15, 2025
Reiterates: Buy
Price Target: $10
Current: $1.30
Upside: +672.20%
Corbus Pharmaceuticals Holdings
May 7, 2025
Maintains: Buy
Price Target: $50 → $40
Current: $7.89
Upside: +406.97%
TScan Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $1.45
Upside: +589.66%
Erasca
Apr 30, 2025
Reiterates: Buy
Price Target: $6
Current: $1.39
Upside: +331.65%
Foghorn Therapeutics
Apr 30, 2025
Reiterates: Buy
Price Target: $13
Current: $4.90
Upside: +165.31%
Sutro Biopharma
Apr 29, 2025
Reiterates: Neutral
Price Target: $2
Current: $0.80
Upside: +150.38%
Protara Therapeutics
Apr 28, 2025
Reiterates: Buy
Price Target: $23
Current: $2.88
Upside: +698.61%
CG Oncology
Apr 28, 2025
Reiterates: Buy
Price Target: $75
Current: $25.66
Upside: +192.28%
Apr 3, 2025
Reiterates: Buy
Price Target: $36
Current: $6.48
Upside: +455.56%
Mar 26, 2025
Maintains: Buy
Price Target: $18 → $6
Current: $2.50
Upside: +140.00%
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $1.25
Upside: +1,100.00%
Mar 11, 2025
Reiterates: Buy
Price Target: $25
Current: $3.02
Upside: +727.81%
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $50
Current: $33.28
Upside: +50.24%
Nov 11, 2024
Reiterates: Buy
Price Target: $4
Current: $1.34
Upside: +198.51%